Madrigal Pharmaceuticals, Inc(NASDAQ:MDGL) 
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is MGL-3196, a liver-directed selective thyroid hormon...
Website: http://www.madrigalpharma.com
Founded: 2011
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 318.69
H 325.08
L 309.00
C 314.39
V 343,493
10EMA 314.39
20EMA 314.39
60EMA 314.39
120EMA 314.39
250EMA 314.39